
October 19, 2023
Pure Life Healthcare Management aims to change the healthcare landscape for people suffering from post-traumatic stress disorder (PTSD) with more than 20 services to support PTSD and trauma, creating a wrap-around healthcare ecosystem that provides patients with everything they need to heal.
The company is backed by an experienced team with a deep understanding of issues surrounding mental health. It is also structured to leverage its own value chain, which includes wrap-around care clinics, occupational therapy, alternative medical treatments, pharmacies and partnerships with organizations such as Heroes Haven Society.
Key Services and PartnershipsPure Life Healthcare Management’s wraparound approach to healthcare will provide support throughout the entire healing process, from counseling and medical testing to dentistry and physiotherapy. The majority of clients are expected to require only a light to medium touch, with one to six visits per month. However, Pure Life also expects a minority of highly complex cases which will require up to $100,000 annually per client with 10 to 20 visits per month.
Company Highlights
- Over 1.3 million Canadians currently struggle with PTSD and trauma, a population largely underserved by the country's mental health services.
- Canada is implementing a National Strategy for PTSD focused on prevention, early treatment and intervention, increasing funding for mental health services and looking for partners.
- Pure Life Healthcare Management is strategically positioned to be among these partners.
- Pure Life Healthcare Management offers more than 20 services to support PTSD and trauma, creating a wrap-around healthcare ecosystem that provides patients with everything they need to heal.
- The company is backed by an experienced leadership team and a business structure designed to maximize the value chain, which includes:
- Wrap-around care clinics
- Pharmacies
- Alternative medicines
- Occupational therapies
- Partnerships
- Joint ventures
- Real estate and commercial holdings
- One of Pure Life Healthcare Management's most prominent partnerships is with the non-profit Heroes Haven Society, which provides free testing and support for individuals suffering from trauma.
- The majority of Pure Life Healthcare Management’s revenue will stem from government and insurance benefits.
- Pure Life Healthcare Management has begun with a virtual model, and is preparing to acquire its first physical location in 2023. The virtual presence will be maintained to serve the remote and restricted community, and as a way to measure patient concentration by area, driving physical location demand and profitability from day one. This strategy is expected to deliver the following revenues:
- Phase 1 (2023): $690,000 with 14,400 clients and one physical location.
- Phase 2 (2024): $29.90 million with 27,000 clients and two physical locations.
- Phase 3 (2025): $90.85 million with 40,000 clients and four physical locations.
This Pure Life Healthcare Management profile is part of a paid investor education campaign.*
Click here to connect with Pure Life Healthcare Management to receive an Investor Presentation
The Conversation (0)
04 November
4 Best-performing Canadian Pharma Stocks of 2025
From established players to up-and-coming firms, Canada's pharmaceutical landscape is diverse and dynamic.Canadian drug companies are working to discover and develop major innovations amidst an increasingly competitive global landscape. Rising technologies such as artificial intelligence are... Keep Reading...
30 October
New Deal Could Spark Invion’s Entry into Pet Cancer Market, CEO Says
Invion’s (ASX:IVX,OTC Pink:IVIXF) Photosoft cancer treatment technology has entered an important milestone, thanks to a new collaboration deal with Taiwanese firm Protect Animal Health, to undertake studies to treat cancer in pets.“The significance of this recent collaboration is (that) now... Keep Reading...
27 October
Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth
Solvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system ("CNS") disorders, is delighted to announce the appointment of Paul Carter as Non-Executive Director, effective 27 October 2025.Paul Carter is a highly... Keep Reading...
23 September
5 Biggest Pharma Stocks in 2025
The pharmaceutical industry is a major player in the overall life science sector, responsible for developing and manufacturing the majority of prescription drugs. Companies in this space are constantly researching and creating innovative treatments for various medical conditions. In recent... Keep Reading...
08 September
Seegnal Inc. Announces Extension of Maccabi Health Services Contract
Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Corporation"), a global leader in SaaS clinical division support solutions, is pleased to announce that effective September 8, 2025, it has amended its contract with Maccabi Health Services ("Maccabi") for an additional six years and has also expanded... Keep Reading...
Latest News
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00





